India said on Tuesday it will permit limited exports of the anti-malaria drug hydroxychloroquine, reported CNBC.
The government there had suspended exports of hydroxychloroquine, as well paracetamol, saying stocks were depleting because of the hit to global supply chains after COVID-19 emerged in China late last year.
However, US President Donald Trump spoke to Prime Minister Narendra Modi recently seeking supplies and on Monday indicated that India may face retaliation if it did not withdraw the ban on exports.
"It has been decided that India would licence paracetamol and hydroxychloroquine in appropriate quantities to all our neighbouring countries who are dependent on our capabilities," said Indian foreign ministry spokesman Anurag Srivastava.
He added that India "will also be supplying these essential drugs to some nations who have been particularly badly affected by the pandemic."
In addition, India said it was lifting curbs on the export of 24 pharmaceutical ingredients and medicines made from them that includes several antibiotics, such as tinidazole and erythromycin, as well as progesterone.
To read more NewsPoints articles, click here.